Skip to the page

Data / Form D filings / Fuse Oncology, Inc.

Fuse Oncology, Inc.: Form D filings

Fuse Oncology, Inc., a health care company in Greensboro, NC, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on April 21, 2023, reports $8.9 million sold of a $9.7 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4214 WEST WENDOVER AVE., #1340, Greensboro, NC, 27407
Phone
(828) 719-8279
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1931320

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 21, 2023New notice$9,687,483$8,859,474$828,00920Apr 6, 2023sec.gov
May 27, 2022New notice$2,951,000$2,951,00018Nov 4, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John MillerDirector
Jay BrennanDirector
Benjamin SintayExecutive Officer
John StriderExecutive Officer
James BaulerExecutive Officer, Director
David WiantExecutive Officer

Other health care companies in North Carolina that filed recently

Every Form D from the week of Apr 17, 2023 · All recent filings in North Carolina · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Fuse Oncology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.